Mucinous carcinoma is a special type of breast cancer whose cells float in pools of mucin. It mostly affects older women, is nearly always hormone-sensitive and rarely spreads to lymph nodes, and the pure form carries one of the best outlooks of any breast cancer.
What is mucinous carcinoma of the breast?
Mucinous carcinoma of the breast is a special type of invasive breast cancer. It is also called colloid carcinoma. Its cancer cells float in pools of mucin, a jelly-like substance that the cells produce themselves. Under the microscope, the tumour looks like small islands of cells scattered in a lake of mucus.
Mucinous carcinoma accounts for only a small share of breast cancers, usually quoted as between 1% and 4% (Kuzmiak and Calhoun, 2023). It is most often diagnosed in older women, typically after the menopause. In a large American registry study of more than 11,000 women with the pure form, the median age at diagnosis was 71 (Di Saverio, Gutierrez and Avisar, 2008).
Doctors divide mucinous carcinoma into pure and mixed forms. Pure mucinous carcinoma is mostly mucin and has a very favourable outlook: it is usually slow growing, rarely spreads to the lymph nodes and is nearly always hormone receptor-positive. Mixed tumours contain areas of ordinary invasive breast cancer and behave more like that type.
Treatment follows the general principles for early hormone-sensitive breast cancer: surgery, often radiotherapy and, in most cases, hormone (endocrine) therapy. Chemotherapy is needed less often than for many other breast cancers.
1. Key facts at a glance
2. Types of mucinous carcinoma
Pure and mixed
In a Tunisian series of 48 patients, pure and mixed tumours were found to behave as two distinct subtypes with different outcomes (El Amine El Hadj et al., 2016).
Cellular subtypes of pure mucinous carcinoma
Conditions that look similar
Mucin production is not unique to mucinous carcinoma, so pathologists take care to distinguish it from other mucin-containing lesions (Rakha, Wazwaz and Fox, 2026).
How it compares with the most common breast cancer
In the registry study, around 86% of women had disease confined to the breast at surgery, about 12% had lymph node involvement and only 2% had distant spread (Di Saverio, Gutierrez and Avisar, 2008).
Mucinous carcinoma in men
Breast cancer in men is rare, and mucinous carcinoma is an uncommon type within it. When it does occur, it is treated in the same way, usually with mastectomy, sentinel node biopsy and tamoxifen.
3. Causes and risk factors
There is no single known cause. Risk factors are broadly the same as for hormone receptor-positive breast cancer.
4. How does it look
On mammography
On ultrasound and MRI
Because it can resemble a benign lesion, a biopsy is important whenever a new mass appears in an older woman (Kuzmiak and Calhoun, 2023).
Under the microscope
To the touch
When a lump can be felt, it is often soft or rubbery and may move easily, which can be falsely reassuring.
5. Symptoms
Common findings
- No symptoms, with the cancer found on screening mammography
- A painless lump in the breast
- A lump that may feel soft or squashy rather than hard
Less common symptoms
When to seek medical advice
See a doctor about any new breast lump, even if it feels soft or moves, and about changes in the skin or nipple. Keep attending breast screening when invited.
6. Diagnosis
A core biopsy may contain mostly mucin, so the final classification as pure or mixed is often confirmed after surgery.
Staging
Mucinous carcinoma is staged with the standard TNM breast cancer system, including tumour size, lymph nodes, spread and the tumour’s receptor status and grade.
The mucin makes tumours larger than their cancer-cell content would suggest, which has led some experts to question how well tumour size predicts outcome in this type (Di Saverio, Gutierrez and Avisar, 2008).
7. Treatment
Surgery
Radiotherapy
In the registry study, adding radiotherapy after surgery did not significantly change overall survival, although it can lower the chance of a local recurrence (Di Saverio, Gutierrez and Avisar, 2008).
Endocrine therapy
Chemotherapy and other treatments
Side effects
What treatment involves day to day
8. Outlook (prognosis)
Pure mucinous carcinoma has one of the best outlooks of any breast cancer type.
These figures come from more than 11,000 women recorded between 1973 and 2002 (Di Saverio, Gutierrez and Avisar, 2008). Outcomes today are likely to be better still with modern treatment.
Late recurrences can occur, so long-term follow-up is worthwhile.
9. Follow-up
10. Living with mucinous carcinoma
- Take endocrine therapy daily and tell your team about side effects; alternatives are available
- Keep active; exercise helps joint aches, mood and bone health
- Look after your bones with calcium, vitamin D and weight-bearing exercise
- Check your breasts and scar and report new lumps or changes
- Limit alcohol and keep a healthy weight, which benefits overall health
- Keep attending screening or follow-up mammograms, even many years after treatment
- Seek support from breast cancer charities and local groups
11. Frequently asked questions
12. Questions to ask your care team
- Is my tumour pure or mixed mucinous carcinoma?
- What are the receptor results and grade?
- Were any lymph nodes involved?
- Do I need radiotherapy, and could I safely avoid it?
- Would a genomic test help decide about chemotherapy?
- Which endocrine therapy do you recommend, and for how long?
- How will my bone health be monitored during treatment?
Resources
- Di Saverio, S., Gutierrez, J. and Avisar, E. (2008) ‘A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma’, Breast Cancer Research and Treatment, 111(3), pp. 541-547.
- El Amine El Hadj, O. et al. (2016) ‘Mucinous breast carcinoma a rare entity to be known: clinico-pathological study of 48 cases’, La Tunisie Medicale, 94(8-9), pp. 525-530.
- Kuzmiak, C.M. and Calhoun, B.C. (2023) ‘Pure mucinous carcinoma of the breast: radiologic-pathologic correlation’, Journal of Breast Imaging, 5(2), pp. 180-187.
- Rakha, E.A., Wazwaz, B. and Fox, S.B. (2026) ‘Mucinous carcinoma of the breast: morphological spectrum, diagnostic pitfalls and classification challenges’, Journal of Clinical Pathology, 79(7), pp. 433-444.
- National Cancer Institute (2026) Breast Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/breast/hp/breast-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.